188 related articles for article (PubMed ID: 2565842)
1. Parenteral antisecretory drug therapy in patients with Zollinger-Ellison syndrome.
Saeed ZA; Norton JA; Frank WO; Young MD; Maton PN; Gardner JD; Jensen RT
Gastroenterology; 1989 Jun; 96(6):1393-402. PubMed ID: 2565842
[TBL] [Abstract][Full Text] [Related]
2. Parenteral control of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
Vinayek R; Hahne WF; Euler AR; Norton JA; Jensen RT
Dig Dis Sci; 1993 Oct; 38(10):1857-65. PubMed ID: 8104773
[TBL] [Abstract][Full Text] [Related]
3. Role of acid suppressants in patients with Zollinger-Ellison syndrome.
Maton PN
Aliment Pharmacol Ther; 1991; 5 Suppl 1():25-35. PubMed ID: 1679671
[TBL] [Abstract][Full Text] [Related]
4. Famotidine: effective treatment of Zollinger-Ellison syndrome.
Howard JM; Vinayek R; Maton PN; Wank SA; Gardner JD; Jensen RT
J Clin Gastroenterol; 1987; 9 Suppl 2():23-5. PubMed ID: 2887615
[TBL] [Abstract][Full Text] [Related]
5. A prospective study of perioperative and postoperative control of acid hypersecretion in patients with Zollinger-Ellison syndrome undergoing gastrinoma resection.
Fraker DL; Norton JA; Saeed ZA; Maton PN; Gardner JD; Jensen RT
Surgery; 1988 Dec; 104(6):1054-63. PubMed ID: 2904182
[TBL] [Abstract][Full Text] [Related]
6. Effects of curative gastrinoma resection on gastric secretory function and antisecretory drug requirement in the Zollinger-Ellison syndrome.
Pisegna JR; Norton JA; Slimak GG; Metz DC; Maton PN; Gardner JD; Jensen RT
Gastroenterology; 1992 Mar; 102(3):767-78. PubMed ID: 1537514
[TBL] [Abstract][Full Text] [Related]
7. Famotidine in the therapy of gastric hypersecretory states.
Vinayek R; Howard JM; Maton PN; Wank SA; Slaff JI; Gardner JD; Jensen RT
Am J Med; 1986 Oct; 81(4B):49-59. PubMed ID: 2877575
[TBL] [Abstract][Full Text] [Related]
8. Comparison of ranitidine and cimetidine in the treatment of gastric hypersecretion.
Collen MJ; Howard JM; McArthur KE; Raufman JP; Cornelius MJ; Ciarleglio CA; Gardner JD; Jensen RT
Ann Intern Med; 1984 Jan; 100(1):52-8. PubMed ID: 6318628
[TBL] [Abstract][Full Text] [Related]
9. Replacement of oral proton pump inhibitors with intravenous pantoprazole to effectively control gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
Metz DC; Forsmark C; Lew EA; Starr JA; Soffer EF; Bochenek W; Pisegna JR
Am J Gastroenterol; 2001 Dec; 96(12):3274-80. PubMed ID: 11774936
[TBL] [Abstract][Full Text] [Related]
10. Intravenous omeprazole in patients with Zollinger-Ellison syndrome undergoing surgery.
Vinayek R; Frucht H; London JF; Miller LS; Stark HA; Norton JA; Cederberg C; Jensen RT; Gardner JD; Maton PN
Gastroenterology; 1990 Jul; 99(1):10-6. PubMed ID: 1971604
[TBL] [Abstract][Full Text] [Related]
11. Famotidine, a new, potent, long-acting histamine H2-receptor antagonist: comparison with cimetidine and ranitidine in the treatment of Zollinger-Ellison syndrome.
Howard JM; Chremos AN; Collen MJ; McArthur KE; Cherner JA; Maton PN; Ciarleglio CA; Cornelius MJ; Gardner JD; Jensen RT
Gastroenterology; 1985 Apr; 88(4):1026-33. PubMed ID: 2857672
[TBL] [Abstract][Full Text] [Related]
12. Long-term lansoprazole control of gastric acid and pepsin secretion in ZE and non-ZE hypersecretors: a prospective 10-year study.
Hirschowitz BI; Simmons J; Mohnen J
Aliment Pharmacol Ther; 2001 Nov; 15(11):1795-806. PubMed ID: 11683694
[TBL] [Abstract][Full Text] [Related]
13. Cimetidine pharmacokinetics in patients with Zollinger-Ellison syndrome.
McArthur KE; Raufman JP; Seaman JJ; Ziemniak JA; Gardner JD; Jensen RT
Gastroenterology; 1987 Jul; 93(1):69-76. PubMed ID: 3582917
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of oral and intravenous omeprazole in patients with the Zollinger-Ellison syndrome.
Vinayek R; Amantea MA; Maton PN; Frucht H; Gardner JD; Jensen RT
Gastroenterology; 1991 Jul; 101(1):138-47. PubMed ID: 2044903
[TBL] [Abstract][Full Text] [Related]
15. Long-term efficacy and safety of omeprazole in patients with Zollinger-Ellison syndrome: a prospective study.
Maton PN; Vinayek R; Frucht H; McArthur KA; Miller LS; Saeed ZA; Gardner JD; Jensen RT
Gastroenterology; 1989 Oct; 97(4):827-36. PubMed ID: 2777040
[TBL] [Abstract][Full Text] [Related]
16. Use of omeprazole in Zollinger-Ellison syndrome: a prospective nine-year study of efficacy and safety.
Metz DC; Strader DB; Orbuch M; Koviack PD; Feigenbaum KM; Jensen RT
Aliment Pharmacol Ther; 1993 Dec; 7(6):597-610. PubMed ID: 8161665
[TBL] [Abstract][Full Text] [Related]
17. Maintenance oral pantoprazole therapy is effective for patients with Zollinger-Ellison syndrome and idiopathic hypersecretion.
Metz DC; Soffer E; Forsmark CE; Cryer B; Chey W; Bochenek W; Pisegna JR
Am J Gastroenterol; 2003 Feb; 98(2):301-7. PubMed ID: 12591045
[TBL] [Abstract][Full Text] [Related]
18. Medical management of patients with Zollinger-Ellison syndrome who have had previous gastric surgery: a prospective study.
Maton PN; Frucht H; Vinayek R; Wank SA; Gardner JD; Jensen RT
Gastroenterology; 1988 Feb; 94(2):294-9. PubMed ID: 3335308
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Zollinger-Ellison syndrome with exploratory laparotomy, proximal gastric vagotomy, and H2-receptor antagonists. A prospective study.
Richardson CT; Peters MN; Feldman M; McClelland RN; Walsh JH; Cooper KA; Willeford G; Dickerman RM; Fordtran JS
Gastroenterology; 1985 Aug; 89(2):357-67. PubMed ID: 2861140
[TBL] [Abstract][Full Text] [Related]
20. Failure of cimetidine in Zollinger-Ellison syndrome.
Ziemniak JA; Madura M; Adamonis AJ; Olinger EJ; Dreyer M; Schentag JJ
Dig Dis Sci; 1983 Nov; 28(11):976-80. PubMed ID: 6628158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
